Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Large Increase in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 1,600 shares. Based on an average daily volume of 20,345 shares, the short-interest ratio is presently 0.1 days.

Fortress Biotech Stock Down 5.2%

Shares of NASDAQ:FBIOP traded down $0.91 during trading on Wednesday, hitting $16.50. The stock had a trading volume of 9,840 shares, compared to its average volume of 19,643. The firm’s fifty day moving average is $18.16 and its 200 day moving average is $17.51. Fortress Biotech has a 12 month low of $6.27 and a 12 month high of $21.43.

Fortress Biotech Company Profile

Fortress Biotech, Inc is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology.

Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization.